SIG | Genetics: When Exome/Genome is Negative - What's Next to Solve the Unsolved Epilepsies

Sunday, December 6, 2026 at 4:00 PM to 5:30 PM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

Exome and genome sequencing are the most comprehensive clinical genetic tests currently available and are increasingly integrated into routine epilepsy care. However, most individuals with unexplained, presumed genetic epilepsy remain “genetically unsolved” after exome and genome sequencing. Identifying genetic diagnoses for these individuals can have important implications for epilepsy care, including impacting work-up, treatment, and prognosis. So what’s next to “solve the unsolved” epilepsies when exome and genome sequencing are nondiagnostic? Through brief case presentations with live polling followed by a moderated panel discussion, in this session we discuss emerging genomic and multi-omic methods to “solve the unsolved” epilepsies.
Learning Objective 1
Discuss the diagnostic yield of exome and genome reanalysis for individuals with unexplained epilepsy and when to consider performing reanalysis
Learning Objective 2
Describe the role of emerging genetic tests like long-read sequencing and deep sequencing in the diagnostic work-up of individuals with unexplained epilepsy
Learning Objective 3
Recognize the importance of complementary multi-omic methodologies, including RNA and methylation analyses, in identifying genetic diagnoses in unexplained epilepsy
Target Audience
CliniciansFellows/TraineesAdvocatesScientists/Researchers
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session Content Includes
Pediatric
Session ID
GENETICSIG26
Presentation Id
3452238
Event ID
24056
Session Type
Session